19-7677166-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000333598.8(MCEMP1):āc.46A>Cā(p.Lys16Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000765 in 1,438,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000333598.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCEMP1 | NM_174918.3 | c.46A>C | p.Lys16Gln | missense_variant | 1/7 | ENST00000333598.8 | NP_777578.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCEMP1 | ENST00000333598.8 | c.46A>C | p.Lys16Gln | missense_variant | 1/7 | 1 | NM_174918.3 | ENSP00000329920 | P2 | |
MCEMP1 | ENST00000597445.1 | c.46A>C | p.Lys16Gln | missense_variant | 1/6 | 3 | ENSP00000471413 | A2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000946 AC: 2AN: 211432Hom.: 0 AF XY: 0.00000881 AC XY: 1AN XY: 113446
GnomAD4 exome AF: 0.00000765 AC: 11AN: 1438218Hom.: 0 Cov.: 31 AF XY: 0.00000701 AC XY: 5AN XY: 713234
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.85A>C (p.K29Q) alteration is located in exon 1 (coding exon 1) of the MCEMP1 gene. This alteration results from a A to C substitution at nucleotide position 85, causing the lysine (K) at amino acid position 29 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at